Latest News

Proposal to fund treatment earlier for relapsing remitting multiple sclerosis

May 30, 2022 | Advocacy, Life with MS, Treatments

We are excited to announce that following 7 years of relentless advocacy by Multiple Sclerosis NZ (MSNZ), Pharmac have opened the consultation process to increase earlier access to treatments for relapsing remitting MS. We now need YOUR HELP to get […]


My aHSCT story – Lucy Kerly

May 23, 2022 | Advocacy, Life with MS, My Story, Treatments

Lucy Kerly had aHSCT on the NHS at Hammersmith Hospital in London at the beginning of 2022. Both she and her husband live with MS – Steve was diagnosed with relapsing MS in 2003 when he was 29 and travelled […]


My aHSCT Story – Bronwyn Hutchison

January 11, 2022 | Life with MS, MS Voice, Newsletter, Treatments

I was 30 years old and working as a civil litigator when I woke up one morning in July 2011 with a complete loss of vision in my right eye. I was diagnosed with optic neuritis and warned of the […]


My aHSCT story – Celia Attwood

December 20, 2021 | Life with MS, MS Voice, Newsletter, Research, Treatments

  My name is Celia Attwood, I’m 32 years old and a mum of 2 beautiful boys. I had been to see my G.P numerous times over the years before being diagnosed with MS but with no definite answers and […]


Covid-19 in Ocrelizumab-treated people with Multiple Sclerosis

January 26, 2021 | Covid-19, Life with MS, Research, Treatments

This article, written by the Journal of Multiple Sclerosis and related disorders,  (MSARD) includes data from clinical trials, post marketing safety surveillance and a US electronic medical records database, Optum. The objective was to better understand the SARS-CoV-2 infection in […]